Search research articles
Contact Us
Filters
Showing results (791-800 of 1,050) with videos related to
Page
of 105
Sort By:
BMJ (Clinical Research Ed.)
|
March 31, 1998
Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms
H L Crimlisk, K Bhatia, H Cope, et al.
Journal of the Neurological Sciences
|
August 1, 1981
Classification of extrapyramidal disorders. Proposal for an international classification and glossary of terms
A Barbeau, R C Duvoisin, F Gerstenbrand, et al.
Neurology
|
January 1, 1985
Validity and reliability of a rating scale for the primary torsion dystonias
R E Burke, S Fahn, C D Marsden, et al.
Neuroscience Letters
|
May 19, 1987
Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessary
C Gibb, J Willoughby, V Glover, et al.
Neuropsychologia
|
January 1, 1989
The performance on learning tasks of patients in the early stages of Parkinson's disease
A G Canavan, R E Passingham, C D Marsden, et al.
Advances in Neurology
|
January 1, 1984
Pergolide in the treatment of Parkinson's disease
N P Quinn, A E Lang, C Thompson, et al.
Human Molecular Genetics
|
March 1, 1996
Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity
O Bandmann, T G Nygaard, R Surtees, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1986
Familial dystonia and visual failure with striatal CT lucencies
C D Marsden, A E Lang, N P Quinn, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1988
Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disorders
D Aubby, H K Saggu, P Jenner, et al.
Lancet (London, England)
|
September 13, 1986
Lipid peroxidation as cause of nigral cell death in Parkinson's disease
D Dexter, C Carter, F Agid, et al.
Page
of 105
Search research articles
Search
Showing results (791-800 of 1,050) with videos related to
Sort By:
Page
of 105
BMJ (Clinical Research Ed.)
|
March 31, 1998
Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms
H L Crimlisk, K Bhatia, H Cope, et al.
Journal of the Neurological Sciences
|
August 1, 1981
Classification of extrapyramidal disorders. Proposal for an international classification and glossary of terms
A Barbeau, R C Duvoisin, F Gerstenbrand, et al.
Neurology
|
January 1, 1985
Validity and reliability of a rating scale for the primary torsion dystonias
R E Burke, S Fahn, C D Marsden, et al.
Neuroscience Letters
|
May 19, 1987
Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessary
C Gibb, J Willoughby, V Glover, et al.
Neuropsychologia
|
January 1, 1989
The performance on learning tasks of patients in the early stages of Parkinson's disease
A G Canavan, R E Passingham, C D Marsden, et al.
Advances in Neurology
|
January 1, 1984
Pergolide in the treatment of Parkinson's disease
N P Quinn, A E Lang, C Thompson, et al.
Human Molecular Genetics
|
March 1, 1996
Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity
O Bandmann, T G Nygaard, R Surtees, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1986
Familial dystonia and visual failure with striatal CT lucencies
C D Marsden, A E Lang, N P Quinn, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1988
Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disorders
D Aubby, H K Saggu, P Jenner, et al.
Lancet (London, England)
|
September 13, 1986
Lipid peroxidation as cause of nigral cell death in Parkinson's disease
D Dexter, C Carter, F Agid, et al.
Page
of 105